MedTrace Logo

Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents

NCT00715780 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1667

Last updated 2016-11-07

No results posted yet for this study

Summary

This study is conducted in Asia. The aim of this observational study is to evaluate the incidence of major hypoglycaemic episodes and other adverse events, and to evaluate efficacy while using insulin under normal clinical practice conditions. The switch from OAD treatment to insulin therapy will be determined by physician.

Conditions

Interventions

DRUG

soluble human insulin

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

biphasic human insulin

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

insulin NPH

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

insulin aspart

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

biphasic insulin aspart

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

insulin detemir

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00715780 on ClinicalTrials.gov